Fiegle, Eva; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
Crysandt, Martina; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
Bouillon, Anne-Sophie ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'hématologie clinique
Silling, Gerda; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
Elbracht, Miriam; Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany
Begemann, Matthias ; Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany
Brümmendorf, Tim H; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
Beier, Fabian ; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
Jost, Edgar ; Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany. Electronic address: ejost@ukaachen.de
Language :
English
Title :
Successful allogeneic stem cell transplantation of a patient with Werner syndrome and acute myeloid leukemia.
Huang, S., Lee, L., Hanson, N.B., Lenaerts, C., Hoehn, H., Poot, M., et al. The spectrum of WRN mutations in Werner syndrome patients. Hum. Mutat. 27:6 (2006), 558–567.
Lauper, J.M., Krause, A., Vaughan, T.L., Monnat, R.J. Jr., Spectrum and risk of neoplasia in Werner syndrome: a systematic review. PLoS One, 8(4), 2013 e59709-e.
Seiter, K., Qureshi, A., Liu, D., Galvin-Parton, P., Arshad, M., Agoliati, G., et al. Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome. Leuk. Lymphoma 46:7 (2005), 1091–1095.
Brümmendorf, T.H., Maciejewski, J.P., Mak, J., Young, N.S., Lansdorp, P.M., Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood 97:4 (2001), 895–900.
Ferreira, M.S.V., Kirschner, M., Halfmeyer, I., Estrada, N., Xicoy, B., Isfort, S., et al. Comparison of flow-FISH and MM-qPCR telomere length assessment techniques for the screening of telomeropathies. Ann. N. Y. Acad. Sci. 1466:1 (2020), 93–103.
Rufer, N., Brümmendorf, T.H., Kolvraa, S., Bischoff, C., Christensen, K., Wadsworth, L., et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 190:2 (1999), 157–167.
Lautrup, S., Caponio, D., Cheung, H.H., Piccoli, C., Stevnsner, T., Chan, W.Y., et al. Studying Werner syndrome to elucidate mechanisms and therapeutics of human aging and age-related diseases. Biogerontology 20:3 (2019), 255–269.
Hayashi, K., Tasaka, T., Kondo, T., Ishikawa, Y., Goto, M., Matsuhashi, Y., et al. Successful cord blood transplantation in a werner syndrome patient with high-risk myelodysplastic syndrome. Intern. Med. 58:1 (2019), 109–113.
Mao, F.J., Sidorova, J.M., Lauper, J.M., Emond, M.J., Monnat, R.J., The human WRN and BLM RecQ helicases differentially regulate cell proliferation and survival after chemotherapeutic DNA damage. Cancer Res. 70:16 (2010), 6548–6555.
Ozgenc, A., Loeb, L.A., Werner Syndrome, aging and cancer. Genome Dyn. 1 (2006), 206–217.
Poot, M., Yom, J.S., Whang, S.H., Kato, J.T., Gollahon, K., Rabinovitch, P.S., Werner syndrome cells are sensitive to DNA cross-linking drugs. FASEB J. 15 (2001), 1224–1226.
